FDA Grants Accelerated Approval to Sunvozertinib for Metastatic Non-Small Cell Lung Cancer with EGFR exon 20 Insertion Mutations By Ogkologos - July 25, 2025 274 0 Facebook Twitter Google+ Pinterest WhatsApp FDA also approved the Oncomine Dx Express Test as a companion diagnostic device Source RELATED ARTICLESMORE FROM AUTHOR New Targeted Therapy Shows Promising Early Results in Advanced Pancreatic Cancer FDA Approves Pivekimab Sunirine-pvzy for Blastic Plasmacytoid Dendritic Cell Neoplasm, an Ultra-Rare Haematologic Malignancy Ivonescimab Plus Chemotherapy Improves OS Compared with Tislelizumab Plus Chemotherapy in Previously Untreated Patients with Advanced Squamous NSCLC MOST POPULAR Hospital Lockdown Prevents Breast Cancer Patient from Receiving Treatment for 3... May 17, 2021 How repurposing a drug in a COVID-19 trial could benefit people... March 2, 2021 FDA Approval Likely to Change Initial Treatment for Some People with... May 2, 2025 How Adolescent and Young Adult Cancer Survivors Can Cope With the... November 17, 2022 Load more HOT NEWS Training Cancer Researchers: A Conversation with Dr. Oliver Bogler 3D-Printed Surgical Guides Are Helping Surgeons Save More Breast Tissue While... Experimental CAR T-Cell Therapy Shrinks Tumors in Children with Deadly Brain... Exceptional Response Rates and Survival Among Patients with POLE/D1 Proofreading Deficient...
